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Abstract
The cytoplasmic tail of Fcg RIIa present on human neutrophils shares with other antigen receptors a common amino acid
 .sequence called ITAM Immunoreceptor Tyrosine-based Activation Motif . After receptor ligation, the tyrosine residues
within this motif become phosphorylated. We prepared a recombinant fusion protein of the cytoplasmic tail of Fcg RIIa
 .  .containing the ITAM with glutathione–S-Transferase GST-CT to characterize the phosphorylation of Fcg RIIa and its
ability to interact with other proteins involved in signal transduction. The GST-CT became phosphorylated in the presence
 .of Lyn, Hck and Syk immunoprecipitated from human neutrophils , but not in the presence of Fgr. Of the active kinases,
 .only Lyn mainly present in the membrane fraction was found to associate with the GST-CT in the absence of ATP. This
association was also observed in immunoprecipitates of Fcg RIIa from resting neutrophils, suggesting that Lyn might be the
kinase responsible for the initial Fcg RIIa phosphorylation. Moreover, we observed specific association of Syk and the p85
subunit of PI 3-kinase after incubation of the GST-CT with neutrophil cytosol. This interaction was dependent on tyrosine
phosphorylation of the GST-CT. Substitution of 269Tyr by Phe almost completely abolished tyrosine phosphorylation of the
fusion protein. Substitution of either 253Tyr or 269Tyr eliminated Syk binding, but only 253Tyr appeared to be essential for
p85 binding. We hypothesize that, upon activation, the membrane-associated Lyn is responsible for the initial tyrosine
phosphorylation of Fcg RIIa, thus creating a docking site for Syk and PI 3-kinase. q 1997 Elsevier Science B.V.
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1. Introduction
Neutrophils play an important role in host defense,
exerting various responses, such as phagocytosis, su-
peroxide production and release of hydrolytic en-
zymes, to kill engulfed micro-organisms. Most of
those responses are initiated through binding of the
Fc domain of an IgG-antigen complex to an Fcg
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w xreceptor on the cells 1 . Two Fcg R are present on
the neutrophil membrane, Fcg RIIa and Fcg RIIIb.
Although both receptors are able to induce neutrophil
activation upon crosslinking, heterotypic clustering of
w xthese receptors results in a synergistic effect 2 . To
understand the mechanism of this synergism, detailed
knowledge on protein interactions with these recep-
tors is mandatory. Unlike other Fcg receptors such as
Fcg RI and IIIA, which are known to be associated
w xwith another protein 3 , Fcg RIIa and FcRIIIb on
human neutrophils do not seem to have such an
associated subunit Masuda and Roos, unpublished
.observations . However, the cytoplasmic tail of
Fcg RIIa itself contains, along with the g-chain and
other subunits of antigen receptors, an amino acid
sequence called ITAM Immunoreceptor Tyrosine-
.based Activation Motif , which has been shown to be
w xinvolved in signal transduction 4 . This motif con-
sists, in Fcg RIIa, of two YXXL sequences separated
by 12 residues. When the tyrosines become phospho-
rylated, these YXXL motives become docking sites
w xfor proteins containing SH2 domains 5 . One of the
earliest events following Fcg RII cross-linking is ty-
rosine phosphorylation of multiple proteins including
w xthe receptor itself 6 . Because Fcg RIIa has no intrin-
sic tyrosine kinase activity, other protein tyrosine
kinases must be involved.
There are, up to now, nine known members of the
Src family of non-receptor protein tyrosine kinases
 .PTK which have been shown to be involved in the
phosphorylation of cell-surface receptors. All share
some common features: a carboxy-terminal kinase
domain, an SH2 domain able to interact with
phosphotyrosine residues, an SH3 domain able to
recognize proline-rich sequences and a 70 amino acid
amino-terminal sequence characteristic for each ki-
nase, the unique region. Moreover, all can be myris-
toylated, important for the anchoring to the inner
w xleaflet of the plasma membrane 7 . These kinases
have been shown to be physically associated with B-
and T-cell receptors and play an important role in the
signal transduction of these receptors. In case of
Fcg RIIa, an association with Fgr has been reported
w xin human neutrophils 8 , and with Hck and Lyn in
w xmonocytic cells 9,10 .
A second group of cytosolic protein tyrosine ki-
nases comprises ZAP70 and Syk. These PTKs have
two tandem SH2 domains which allow them to bind
preferentially to the two phosphorylated tyrosines
present in the same ITAM. This ITAM binding in-
w xcreases the activity of these kinases 11,12 . Syk has
been shown to be phosphorylated after Fcg RII
w xcross-linking in HL-60 cells 13 and to be physically
associated with phosphorylated Fcg RII in platelets
w x14,15 .
PI 3-kinase has been shown to be involved in a
w xwide variety of cellular responses 16–18 . p85, the
regulatory subunit of PI 3-kinase, has two SH2 do-
mains enabling it to bind to tyrosine phosphorylated
w xreceptors such as CD19 in activated B cells 19 . A
role for PI 3-kinase in Fcg R cross-linking was first
w xsuggested by Ninomiya et al. 20 on the basis of
experiments with U937 cells. We observed a rapid
translocation of PI 3-kinase to the membrane after
Fcg R cross-linking in human neutrophils, even prior
to the generation of InsP and elevation of cytosolic3
2q w xfree Ca 21 . Moreover, two different inhibitors of
PI 3-kinase block these early signal transduction
w xevents 21 .
In the current model for signal transduction through
w xITAM-containing proteins 22 , receptor cross-linking
leads to transphosphorylation by receptor-associated
Src-family kinases of opposing receptor ITAMs. This
causes first a change in mechanism of the kinase–re-
ceptor association: from a binding via the kinase
 .unique region to an SH2- pY ITAM interaction. But
subsequently, other SH2-containing proteins such as
Syk, Shc, and PI 3-kinase, can effectively compete
for the double phosphorylated ITAM and can dis-
w xplace the original kinase 22 . In the study described
here, we investigated the role of the tyrosine residues
in the Fcg RIIa cytoplasmic tail in its phosphorylation
and the binding of SH2-containing proteins.
2. Experimental procedures
2.1. Reagents and chemicals
Rabbit antibodies against Hck, Lyn, and Syk were
purchased from Santa Cruz Biotechnology Santa
. w xCruz, California, U.S.A. . Antiserum against Fgr 23
was kindly donated by Dr. G. Berton University of
.Verona, Italy . Mouse monoclonal antiphosphotyro-
 . sine 4G10 was obtained from UBI Lake Placid,
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.New York, U.S.A. . The anti-human Fcg RIII mAb
 . w xCLBFcgran1 mIgG2a 24 and the anti-human
 . w xFcg RII mAb IV.3 mIgG2b 25 were purified from
hybridoma culture supernatant by precipitation with
50% saturated ammonium sulfate and subsequent
protein A chromatography. A polyclonal rabbit anti-
serum directed against the cytoplasmic tail of Fcg RIIa
was generated in our laboratory by coupling of a
 .synthetic peptide CYLTLPPNDHVNSNN to key-
 .hole limpet hemocyanin KLH . The last 14 residues
in this peptide correspond to the Fcg RIIa carboxy-
terminal end, the cysteine being added to the N-
terminus to allow coupling. After 3 immunizations in
 .complete Freud’s adjuvant, serum designated CT10
was collected and IgG was purified on a protein
 .A-Sepharose column Pharmacia, Uppsala, Sweden .
A 1000-fold dilution of purified CT10-antibodies rec-
ognized on a Western blot a 40-kD band in a neu-
trophil lysate or in an immunoprecipitate obtained
w xwith mAb IV.3 directed against Fcg RII 25 . More-
over, the antibody was only positive in FACS analy-
sis only after digitonin permeabilization of the neu-
trophils. All these were blocked in the presence of the
synthetic peptide depicted above. Monoclonal anti-
GST antibody was a kind gift of Dr. M. Gebbink
Netherlands Cancer Institute, Amsterdam, The
.Netherlands . Anti-p85 antibodies were raised in rab-
bits against purified recombinant p85 as described
w x previously 26 .The proteinase inhibitors DFP diiso-
.  wpropylfluorophosphate , TPCK L-1-chloro-3- 4-
x .tosylamido -4-phenyl-2-butanone , pepstatin and leu-
peptin were from Sigma Chemical Co. St. Louis,
. Missouri, U.S.A. , Pefablock from Merck Darms-
.tadt, Germany .
2.2. GST-CT production
 .The coding sequence of the cytoplasmic tail CT
 .of Fcg RIIa aa 206-282 was amplified from mono-
cytes cDNA by PCR, then cloned into bacterial ex-
pression vector pGEX-2T Pharmacia, Uppsala, Swe-
.den to produce a fusion protein of CT with glu-
 .tathione–S-transferase GST-CT . In addition, a plas-
 . mid encoding GST fused to Syk 5-278 containing
.the two SH2 domains of Syk was generously pro-
vided by Dr. Jurgen Wienands Max-Planck-Institut¨
.fur Immunbiologie, Freiburg, Germany and pro-¨
cessed as described below. Bacterial cultures were
induced with 0.2 mM of isopropyl-1-thio-b-D-
 .galactopyranoside IPTG and grown overnight at
288C. The cells were lysed in NP40 lysis buffer see
.  .above supplemented with lysozyme 250 mgrml by
incubation for 30 min at 48C. The lysate was cen-
 .trifuged 14 000=g, 10 min and the fusion proteins
were affinity purified on gluthatione–agarose
 .Sigma . Protein concentrations were estimated with
 .the BCA method Pierce, Rockfort, Illinois, U.S.A.
following the manufacturer’s instructions. The fusion
protein containing the two SH2 domains of Syk was
w xcut from the GST by thrombin cleavage 27 . Stan-
dard PCR techniques were used to construct point
mutants of the GST-CT fusion protein, in which each
Tyr of the cytoplasmic tail was changed into Phe
 .Y246FsY1F; Y253FsY2F; Y269FsY3F . The
accuracy of the DNA products was checked by Taq-
 .Track DNA sequencing Promega .
2.3. Isolation and incubation of neutrophils
Neutrophils were isolated from blood obtained
from healthy donors by Percoll density gradient cen-
w xtrifugation as described before 28 . After 2 washes in
 7 .PBS, neutrophils 10 rml were resuspended in incu-
bation medium 20 mM Hepes, 132 mM NaCl, 6 mM
KCl, 1 mM CaCl , 1 mM MgSO , 1.2 mM KP , 5.52 4 i
 .mM glucose, 0.5% wrv human serum albumin, pH
.7.4 and incubated at 378C for 5 min with 5 mgrml
of biotinylated Fab fragments of mAb IV.3 and mAb
w xCLBFcgran1 2 . The cells were centrifuged and re-
suspended in fresh incubation medium at 378C.
Cross-linking was performed by adding 1.5 mgrml
 .of streptavidin Sigma with continuous stirring, rest-
ing cells were not exposed to streptavidin. Stimula-
tion was stopped by addition of a ten-fold excess of
ice-cold PBS.
2.4. Neutrophil fractionation
 8 .The cells were resuspended 10 rml in ice-cold
sonication buffer 10 mM Hepes, 150 mM NaCl, 170
mM sucrose, 1 mM EGTA, 1 mM sodium vanadate,
. pH 7.4 with proteinase inhibitors added 1 mM
Pefablock, 50 mM TPCK, 50 mM leupeptin, 1 mM
.  .pepstatin and treated with DFP 1 mM and pheny-
 .larsine oxide PAO, 25 mM for 10 min at 48C. After
centrifugation, the cells were resuspended in the same
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buffer without DFP and PAO and disrupted by soni-
 .cation 3= 15 s, 8-mm amplitude . After centrifuga-
 .tion 10 min, 800=g , 1.5 ml of postnuclear super-
natant were layered on a discontinuous sucrose gradi-
 .ent consisting of layers of 15% wrv , 40%, and
 .52% sucrose and centrifuged 30 min, 100 000=g
 .at 48C. The top phase 1.0 ml of cytosol and the
 .15r40% interphase 0.4 ml of plasma membranes
were collected and frozen.
2.5. Immunoprecipitation and in ˝itro kinase assay
Plasma membranes adjusted to 0.2 mg of pro-
. teinrml were first solubilized in lysis buffer 10 mM
Hepes, 150 mM NaCl, 1 mM EGTA, 1% NP-40, 1
mM sodium vanadate, pH 7.4 plus the proteinase
.inhibitors indicated above . For immunoprecipitation
of Fcg RIIa, 60 mM octyl-D-glucoside was used in-
stead of NP-40. After incubation for 30 min on ice,
the preparation was cleared by centrifugation 14.000
.=g, 10 min . The solubilized membranes and cy-
tosol sample were precleared by incubation with pro-
tein G-Sepharose beads for 1 h at 48C and subse-
quently incubated with an appropriated amount of
antibodies bound to protein G-Sepharose. After 90-
min incubation at 48C, the protein G-Sepharose beads
were washed four times with ice-cold lysis buffer.
For measurement of tyrosine kinase activity in the
immunoprecipitate, the beads were washed once in
kinase buffer 20 mM Tris-HCl, 150 mM NaCl, 50
mM ATP, 5 mM MnCl , 1 mM MgCl , 1 mM2 2
.sodium vanadate, pH 7.4 , then resuspended in kinase
buffer in a final volume of 100 ml in the presence or
absence of 10 mg of GST-CT fusion protein as
substrate. The samples were incubated at 258C for 15
min with continuous shaking. The reaction was
stopped by adding 50 mM EDTA. The beads were
spun down and resuspended in non-reducing Laemmli
w xbuffer 29 . Adsorbed proteins were separated by
 .SDS-PAGE 10% acrylamide and analyzed by West-
ern blot.
2.6. GST-CT binding studies
To measure binding to unphosphorylated GST-CT,
 .glutathione beads having bound GST-CT 10 mgrml
were incubated with neutrophil membranes or cytosol
 6derived from 50=10 neutrophils, diluted in 1 ml
.of lysis buffer for 2 h at 48C. After washing, the
beads were resuspended in 100 ml kinase buffer and
subjected to an in vitro kinase assay as described
above. To measure binding to phosphorylated fusion
protein, 10 mg of either recombinant GST, GST-CT
and the different GST-CT mutant proteins adsorbed
.on glutathione–agarose were incubated with solubi-
lized neutrophil membrane fraction 200 ml, diluted
.into 500 ml of kinase buffer for 2 h at 48C. The
beads were washed four times, resuspended in 100 ml
of kinase buffer and incubated for 10 min at 378C to
obtain a more complete phosphorylation by the asso-
 .ciated kinase see text . After one additional wash,
the beads were incubated with cytosol 1 mg pro-
.teinrml for 120 min at 48C in 1.0 ml of lysis buffer.
The beads were washed four times in ice-cold lysis
buffer and finally resuspended in reducing Laemmli
buffer. Adsorbed proteins were separated by SDS-
 .PAGE 10% acrylamide and analyzed by Western
blot.
2.7. Western blot
After electrophoresis, the proteins were electro-
transferred to nitrocellulose membranes. Unoccupied
sites were blocked with 5% skimmed milk in TBST
buffer 20 mM Tris-HCl, 150 mM NaCl, 0.1% Tween
.20, pH 8.0 and the blot was probed with antibodies
diluted in 2.5% skimmed milk in TBST for 1 h.
Thereafter, the blot was washed and incubated with
the secondary, HRP-conjugated antibody CLB, Ams-
.terdam, The Netherlands . Finally, bound antibodies
were detected by enhanced chemiluminescence
 .Boehringer Mannheim, Germany . When necessary,
the blots were stripped by incubation in 62.5 mM
 .Tris-HCl pH 6.8 containing 2% SDS and 100 mM
b-mercaptoethanol at 508C for 30 min prior to wash-
ing in TBST and reprobing.
3. Results
3.1. Fcg RIIa phosphorylation by ˝arious tyrosine
kinases
To investigate protein interactions with Fcg RIIa,
 .the cytoplasmic tail CT of this receptor was ex-
pressed as a fusion protein with glutathione–S-trans-
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Fig. 1. Characterization of the GST-CT fusion protein. Bacteria
containing a pGEX plasmid encoding GST coupled to the cyto-
plasmic tail of Fcg RIIa were induced with IPTG and lysed as
described in Section 2. Subsequently, the GST-CT fusion protein
was isolated with glutathione–agarose beads. The figure shows
 .the immunoblot of bacterial lysate lane 1 , purified GST-CT
 .  .lane 2 and purified GST lane 3 incubated with rabbit antibod-
 .ies recognizing the cytoplasmic tail anti-CT10, left panel and a
 .monoclonal antibody directed against GST right panel .
 .ferase GST and coupled to glutathione–agarose
beads. Fig. 1 shows the immunoblot with an anti-
serum raised against a synthetic peptide derived from
the C-terminus of the tail, which recognized a protein
with an apparent molecular mass of 35 kD. A protein
of the same size was recognized with an anti-GST
 .antibody Fig. 1 .
We next investigated a possible specific role of
Src-like tyrosine kinases in Fcg RIIa phosphorylation
by using the purified GST-CT fusion protein as a
substrate for various kinases. Fgr, Hck and Lyn are
the most prominent Src-like kinases expressed in
w xneutrophils 30 . There are several isoforms of these
proteins with different intracellular distributions. Hck
is present in both the membrane and cytosol fraction
of neutrophils, whereas Fgr and Lyn are mainly
 .membrane-associated data not shown . On the other
hand, Syk, another tyrosine kinase, is completely
 .cytosolic data not shown . Thus, we immunoprecipi-
tated Fgr and Lyn from the membrane fraction and
Hck and Syk from the cytosol fraction of resting
neutrophils and mixed these immunoprecipitates with
the GST-CT fusion protein. Hck, Lyn and Syk im-
munoprecipitates were all able to tyrosine phosphory-
late the GST-CT fusion protein, but the Fgr immuno-
 .precipitate was clearly not Fig. 2 .
3.2. Lyn association with Fcg RIIa
We next tested whether the cytoplasmic domain of
Fcg RIIa is able to interact with the Src-like kinases
in resting conditions. The unphosphorylated GST-CT
fusion protein was used as a probe to bind proteins
from cytosol and NP40-solubilized membranes. The
adsorbed proteins were subjected to an in vitro kinase
assay, separated by SDS-PAGE and blotted with
 .anti-phosphotyrosine antibodies Fig. 3, left panel .
Tyrosine phosphorylation of the GST-CT fusion pro-
tein due to adsorbed membrane proteins was much
 .  .Fig. 2. Phosphorylation of GST-CT by various kinases. Membranes in the case of Fgr and Lyn and cytosol for Hck and Syk from
x630=10 neutrophils were used to immunoprecipitate tyrosine kinases with the appropiate antibodies as described in Section 2. The
 .  .protein G beads were subjected to an in vitro kinase assay for 15 min at 258C in the absence y or presence q of the GST-CT fusion
protein. Tyrosine phosphorylation was assessed with anti-phosphotyrosine antibodies. The position of the GST-CT fusion protein is
 .  .  .  .marked with an arrow. Lyn lanes 1 and 2 ; Hck lanes 3 and 4 ; Fgr lanes 5 and 6 ; Syk lanes 7 and 8 . Results are representative of at
least two experiments.
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Fig. 3. Tyrosine kinase activity binding to the GST-CT fusion
 .protein. GST-CT 10 mg, bound to glutathione–agarose was
 6incubated with membranes or cytosol isolated from 50=10
.neutrophils in lysis buffer for 120 min at 48C. After washing, the
glutathione–agarose beads were subjected to an in vitro kinase
 .assay. A Western blot with anti-phosphotyrosine antibodies to
 .assess tyrosine phosphorylation. B Reprobing of the same blot
with anti-Lyn antibodies. Results are representative of at least
three experiments.
higher than with adsorbed cytosolic proteins. Two
associated proteins of about 60 kD were also tyrosine
phosphorylated. After reblotting with specific anti-
bodies, these two bands were identified as the two
 .Lyn isoforms Fig. 3, right panel , suggesting a spe-
cific association with unphosphorylated Fcg RIIa.
Neither Fgr nor Hck were detectable in these samples
 .data not shown .
An association of Lyn with Fcg RIIa was also
suggested by immunoblot analysis of Fcg RIIa im-
 .munoprecipitated from human neutrophils Fig. 4 .
Both in resting neutrophils and in neutrophils acti-
vated via Fcg R cross-linking, co-immunoprecipita-
tion of Lyn with Fcg RIIa was observed. Comparison
of the specific Lyn signal obtained with a graded
amount of neutrophil membranes indicated that about
5% of the Fcg RIIa receptors were associated with
 .Lyn data not shown .
3.3. Interaction of cytosolic proteins with phosphory-
lated GST-CT
To further investigate the involvement of cytosolic
proteins in the Fcg RIIa signal transduction pathway,
the phosphorylated GST-CT was used to affinity-
purify proteins from neutrophil cytosol. The fusion
protein was first incubated with neutrophil mem-
branes in the presence of ATP to allow tyrosine
phosphorylation prior to washing and incubation with
cytosol from resting neutrophils. Using specific anti-
 .bodies we identified Syk Fig. 5A and p85, the
 .regulatory subunit of PI-3 kinase Fig. 5B as two of
the proteins that had bound to phosphorylated GST-
CT. These interactions were not observed in the
presence of GST alone and were dependent on GST-
 .Fig. 4. Association of Lyn with Fcg RIIa in human neutrophils. Neutrophils were incubated under resting conditions lanes 1 and 3 or
 .stimulated by cross-linking of Fcg RIIa and Fcg RIIIb lanes 2 and 4 as described in Section 2. After 15 s of stimulation, neutrophils
were fractionated and the membrane fraction derived from 50=106 neutrophils was used to immunoprecipitate Fcg RIIa with mAb IV.3
 .  .lanes 1 and 2 . As control, the various membrane fractions were treated with mIgG2b coupled to protein G-Sepharose lanes 3 and 4 .
 .  .The immunoprecipitates were checked by immunoblot analysis for the presence of Fcg RIIa A with anti-CT10 antiserum or Lyn B
with anti-Lyn antibodies.
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Fig. 5. Specific association of cytosolic proteins with phosphory-
 .lated GST-CT. GST 10 mg, lanes 1 and 3 or GST-CT fusion
 .protein 10 mg, lanes 2 and 4 bound to glutathione–agarose
were incubated with neutrophil membranes in the absence lanes
.  .1 and 2 or presence lanes 3 and 4 of ATP as described in
Section 2. After washing, the glutathione–agarose beads were
 .  .incubated 1.0 ml with neutrophil cytosol 1 mgrml for 120
min at 48C. After washing, adsorbed proteins were resolved by
 .SDS-PAGE, transferred to nitrocellulose and probed with A
 .anti-Syk and B anti-p85 antibodies. In the left lane, neutrophil
 .cytosol C was analyzed as a positive control for the im-
munoblot.
 .Fig. 6. Effect of Syk 5-278 on Syk binding to phoshorylated
 . GST-CT. GST 10 mg, lane 1 or GST-CT fusion protein 10 mg,
.lanes 2 and 3 bound to glutathione–agarose were phosphorylated
and incubated as described in the legend to Fig. 5. In the
 .incubation with neutrophil cytosol loaded in lane 2, Syk 5-278
 .50 mg was added as well. Adsorbed proteins were resolved by
SDS-PAGE, transferred to nitrocellulose and probed with anti-Syk
antibodies. The arrow indicates the position of the normal Syk
protein.
CT phosphorylation, because binding was not ob-
served in the absence of ATP. Both proteins were
absent from the GST-CT beads prior to the incuba-
 .tion with cytosol data not shown .
The binding of Syk to the GST-CT fusion protein
was blocked in the presence of the tandem SH2
 .domains of Syk Fig. 6 , showing the specific role of
these domains in the binding to phosphorylated GST-
CT. In accordance with data obtained with other
w xITAMs able to bind Syk 11,31 , autophosphorylation
of Syk increased when the GST-CT was added to the
 .immunoprecipitated kinase Fig. 7 .
3.4. Differential roles of tyrosine residues in Fcg RIIa
To investigate the role of the three different ty-
rosines present in the cytoplasmic tail of Fcg RIIa,
we generated point mutated GST-CT fusion proteins
in which each of these tyrosine residues was changed
 .into a phenylalanine Y1F, Y2F, Y3F . The 2nd and
3rd tyrosine residue are contained in the ITAM motif,
 .whereas the most N-terminal tyrosine in the tail Y1
has been shown to moderately influence phagocytosis
w xin COS transfectants 32 . Substitution of Y3 severely
compromised total tyrosine phosphorylation of the
GST-CT fusion protein, while the Y2F substitution
had a lower and the Y1F substitution had almost no
 .effect Fig. 8A . Substitution of Y1 decreased Syk
binding to the fusion protein, whereas substituting
either Y2 or Y3 inhibited this binding completely
 .Fig. 8B . The binding of p85 was completely blocked
Fig. 7. Effect of GST-CT on Syk autophosphorylation. A Syk
immunoprecipitate of neutrophil cytosol was obtained as de-
 .scribed in Fig. 1, and incubated in the absence y or presence
 .q of GST-CT fusion protein. Subsequently, samples were
analyzed by immunoblotting with anti-phosphotyrosine antibod-
ies. Only the part, containing the Syk protein indicated by the
.arrow is shown.
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Fig. 8. Effect of mutations in the GST-CT fusion protein on
tyrosine phosphorylation, Syk binding and p85 binding. Different
mutant proteins of GST-CT were prepared as described in Sec-
tion 2, in which each tyrosine of the cytoplasmic tail Y1, Y2 and
.  .Y3 was replaced by a phenylalanine F . The wild-type GST-CT
 .  .fusion protein wt and the mutant proteins Y1F, Y2F, Y3F
bound to glutathione–agarose were incubated with neutrophil
membranes in the presence of ATP, washed and subsequently
 .incubated with neutrophil cytosol in the absence of ATP. A
Measurement of tyrosine phosphorylation on adsorbed proteins
 .with anti-phosphotyrosine monoclonal antibody; B Western blot
 .with anti-Syk antibodies; C Western blot with anti-p85 antibod-
ies. Results shown are representative of three experiments.
in the Y2F mutant protein, whereas the substitutions
 .in Y1 and Y3 had a much smaller effect Fig. 8C .
4. Discussion
In this study we investigated early events after
Fcg R cross-linking in neutrophils by analysis of
protein interactions with the cytoplasmic tail of
Fcg RIIa. The role of tyrosine phosphorylation and of
the Src-family of tyrosine kinases has clearly been
established in the signal transduction of immunologi-
cal receptors, such as the B-cell receptor involving
. w xLyn, Fyn, Blk, Lck, and Fgr 33–35 , the T-cell
 w x w x.receptor involving Fyn 36 and Lck 37 , the FceRI
 w x. involving Lyn 38 and Fcg RIIIA involving Lck
w x.39 . A role for Lyn and Hck in Fcg RII-mediated
signal transduction in the monocytic cell line THP1
w xhas also been suggested 9,40 . We investigated the
possible role in the tyrosine phosphorylation of
Fcg RIIa in neutrophils of any of the three Src-family
tyrosine kinases predominantly expressed in neu-
w xtrophils: Fgr, Hck and Lyn 30 . We observed that
both Hck and Lyn immunoprecipitates, but not Fgr
immunoprecipitates phosphorylated the cytoplasmic
tail of Fcg RIIa coupled to GST. Previously, phos-
phorylation of Fcg RIIa by Src and by Fyn has been
w xreported 41,42 . Thus, it seems that the cytoplasmic
tail of Fcg RIIa can be a substrate for a wide variety
of PTK except for Fgr. Surprisingly, Fgr is the only
Src-like PTK which has been previously reported to
w xbe associated with Fcg RIIa in neutrophils 8 . Possi-
bly, there is a role for Fgr other than tyrosine phos-
phorylation of the receptor itself.
In the course of our studies, we observed co-im-
munoprecipitation of Fcg RIIa when antibodies
 .against membrane-associated kinases Fgr and Hck
were used for precipitation, but not vice-versa. A
similar observation in THP-1 cells has been reported
w xfor Hck 9 . This association was probably due to the
interaction of the Fc part of the precipitating antibod-
ies with the Fc receptor, because the co-immuno-
precipitation was abolished in the presence of IV.3
 .Fab fragments a blocking Fcg RII antibody . These
results warrant caution in the interpretation of co-im-
munoprecipitation experiments. However, when an in
vitro kinase assay was carried out with that non-
specifically bound Fcg RIIa, we observed, in accor-
dance with the results discussed above, that Hck
could phosphorylate the receptor, but Fgr could not
 .data not shown .
Our results indicate that only Lyn associates with
the unphosphorylated tail of Fcg RIIa. We found
association of Lyn with the nonphosphorylated GST-
 .CT fusion protein in vitro Fig. 3 as well as with
 .Fcg RIIa derived from resting neutrophils Fig. 4 . In
both cases, tyrosine phoshorylation of Fcg RIIa oc-
 .curred upon addition of ATP data not shown . Prob-
ably, the physiological activation mechanism is
w xtransphosphorylation in a dimerized complex 43 ,
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which is then mimicked on the beads used for bind-
ing of Fcg RIIa or the GST-CT fusion protein. It is
known that GST fusion proteins can form dimers and
w xthereby activate tyrosine kinases 44 .
An association of Lyn with Fcg RIIa in resting
THP-1 cells can also be derived from the data pub-
w xlished by Ghazizadeh et al. 9 , although these au-
thors emphasized the clear increase in this association
upon Fcg RIIa crosslinking. We did not observe such
an increase, although an increase in autophosphoryla-
tion of Lyn was observed after activation data not
. w xshown . Clark et al. 45 have shown that Lyn and
Fyn can specifically bind to the nonphosphorylated
tail of Ig-a via a sequence between the conserved
ITAM tyrosines. The kinase unique region seems to
w xbe involved in that interaction 46 . Lyn is also
activated by a wide variety of neutrophil agonists
w xincluding immune complexes 47 . Taken together,
these data strongly suggest that Lyn plays an impor-
tant role in the initial tyrosine phosphorylation of
Fcg RIIa.
It is clear that the phosphorylated ITAM functions
as a scaffold to recruit and organize effector molecules
w xfollowing receptor ligation 22 . Syk seems to play a
major role in phagocytosis, because chimeric trans-
membrane proteins containing only the Syk catalytic
domain are capable of triggering phagocytosis in
w xCOS cells 48 . Recently, the importance of Syk for
the signal transduction by Fcg RIIa has recently been
revealed by anti-sense experiments in cultured mono-
w xcytes 49 . On the other hand, Syk coexpression
dramatically enhanced phagocytosis in Fcg RIrg and
IIIrg cotransfected COS cells, but had only a small
effect in Fcg RII-transfected cells, perhaps due to the
original high phagocytic index of Fcg RII-transfected
cells without Syk. No other coexpressed PTK had
w xany effect 50 . In our experiments, we demonstrated
specific association of Syk to the phosphorylated
GST-CT. We have shown that Syk binding was
achieved through its tandem SH2 domains to both
C-terminal phosphotyrosines, because substitution of
 .Y2 or Y3 totally abolished that binding Fig. 8B .
The specific sequence for Syk binding has been
w xestablished as YXXIrL 51 , which is present in both
Y2 and Y3. Moreover, autophosphorylation of Syk, a
generally accepted measurement of activity, was
found to be increased when the GST-CT was added
 .to the immunoprecipitated kinase Fig. 6 . A similar
w xconclusion was drawn recently by Chacko et al. 52 ,
who showed that only double phosphorylated pep-
tides spanning the ITAM of Fcg RIIa were able to
bind with high affinity to Syk.
We have also shown binding of p85, the regulatory
subunit of PI 3-kinase, to the phosphorylated GST-
CT. PI-3 kinase has been implicated previously in
w xFcg R signalling 21,53,54 . Our results with respect
to p85 binding differ in one aspect from those re-
w xcently published by Chacko et al. 52 . These authors
only observed p85 binding to phosphopeptides span-
ning the Fcg RIIa-ITAM with lysates of activated
platelets, indicating the requirement for an activated
intermediate. We observed binding with cytosol of
resting neutrophils, which was even detectable in the
Y3F mutant of the GST-CT fusion protein that was
 .only poorly phosphorylated Fig. 8 . It is noteworthy,
that the consensus sequence of p85 binding to phos-
 w x.phorylated targets pYMrVXM 55 is absent from
the cytoplasmic tail of Fcg RIIa. However, binding of
p85 independent of phosphorylation has previously
w xbeen observed with Ig-a and Ig-b subunits 45 .
Clearly, the precise requirements of p85 binding to
the cytoplasmic tail of Fcg RIIa remain to be estab-
lished. The poor phosphorylation of the Y3F mutant
might point to an important role of 269Tyr in increas-
ing Lyn binding via its SH2 domain, a mechanism
suggested to be of importance for Src-like kinases
w x56 .
In conclusion, the results of our study suggest that
in human neutrophils Lyn, due to its association with
Fcg RIIa, is responsible for the initial phosphoryla-
tion of Fcg RIIa. When the 1st tyrosine in the ITAM
of Fcg RIIa becomes phosphorylated, binding of p85
can take place, whereas for binding of Syk both
tyrosines of the ITAM need to be phosphorylated.
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